ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Collaboration Deal with Sarepta Includes $825 Million Upon Closing On November 26, 2024, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced ...

H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on Arrowhead (ARWR) to $80 from $60 and keeps a Buy rating on the ...

Sarepta Therapeutics (SRPT), the leader in precision genetic medicine for rare diseases announced an exclusive global licensing and collaboration agreement with Arrowhead (ARWR) Pharmaceuticals ...

H.C. Wainwright lowered the firm’s price target on Sarepta (SRPT) to $75 from $80 and keeps a Sell rating on the shares. Sarepta’s deal to ...

Needham lowered the firm’s price target on Sarepta (SRPT) to $202 from $205 and keeps a Buy rating on the shares. The deal with Arrowhead (ARWR) offers platform diversification with clear long-term ...

Sarepta's investments are significant ... which is consistent with Arrowhead's own forward-look estimate "into 2028." ARWR Stock: Operational Progress and Stock Performance Diverge Despite ...

Q4 2024 Earnings Call Transcript November 26, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

The revision follows Sarepta's announcement of a major collaboration with Arrowhead Pharmaceuticals (NASDAQ:ARWR) that significantly expands its product pipeline. Sarepta Therapeutics disclosed ...

In other recent news, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported a transformative fiscal year, marked by a significant collaboration with Sarepta Therapeutics (NASDAQ:SRPT) and progress in ...

The revision follows Sarepta's announcement of a major collaboration with Arrowhead Pharmaceuticals (NASDAQ:ARWR) that significantly expands its product pipeline. Sarepta Therapeutics disclosed its ...

In other recent news, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported a transformative fiscal year, marked by a significant collaboration with Sarepta Therapeutics (NASDAQ:SRPT) and progress in its ...

Bernstein lowered the firm’s price target on Arrowhead (ARWR) to $24 from $27 and keeps ... on the large collaboration deal announced with Sarepta (SRPT) (SPRT) and implications for its own ...